391 related articles for article (PubMed ID: 26975734)
1. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
2. Whatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis.
Frömel T; Fleming I
Antioxid Redox Signal; 2015 May; 22(14):1273-92. PubMed ID: 25330284
[TBL] [Abstract][Full Text] [Related]
3. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
Frömel T; Hu J; Fleming I
Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids.
Arnold C; Konkel A; Fischer R; Schunck WH
Pharmacol Rep; 2010; 62(3):536-47. PubMed ID: 20631419
[TBL] [Abstract][Full Text] [Related]
5. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function.
Spector AA; Fang X; Snyder GD; Weintraub NL
Prog Lipid Res; 2004 Jan; 43(1):55-90. PubMed ID: 14636671
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotective mechanisms of cytochrome P450 derived oxylipins from ω-3 and ω-6 PUFAs.
Cho C; Aliwarga T; Wiley AM; Totah RA
Adv Pharmacol; 2023; 97():201-227. PubMed ID: 37236759
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.
Spector AA; Kim HY
Biochim Biophys Acta; 2015 Apr; 1851(4):356-65. PubMed ID: 25093613
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the Effect of Sorafenib on Omega-6 and Omega-3 Epoxyeicosanoid Formation in Patients with Hepatocellular Carcinoma.
Leineweber CG; Pietzner A; Zhang IW; Blessin UB; Rothe M; Schott E; Schebb NH; Weylandt KH
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182938
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-derived epoxyeicosatrienoic acids and vascular function.
Fleming I; Busse R
Hypertension; 2006 Apr; 47(4):629-33. PubMed ID: 16490839
[TBL] [Abstract][Full Text] [Related]
10. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart.
Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO
Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 epoxygenases as EDHF synthase(s).
Fleming I
Pharmacol Res; 2004 Jun; 49(6):525-33. PubMed ID: 15026030
[TBL] [Abstract][Full Text] [Related]
12. From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: Epoxyeicosatrienoic acids (EETs) and cell signaling.
Michaelis UR; Fleming I
Pharmacol Ther; 2006 Sep; 111(3):584-95. PubMed ID: 16380164
[TBL] [Abstract][Full Text] [Related]
13. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
Fleming I
Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome p450 and vascular homeostasis.
Fleming I
Circ Res; 2001 Oct; 89(9):753-62. PubMed ID: 11679404
[TBL] [Abstract][Full Text] [Related]
15. The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease.
Fleming I
Pharmacol Rev; 2014 Oct; 66(4):1106-40. PubMed ID: 25244930
[TBL] [Abstract][Full Text] [Related]
16. Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system.
Larsen BT; Campbell WB; Gutterman DD
Trends Pharmacol Sci; 2007 Jan; 28(1):32-8. PubMed ID: 17150260
[TBL] [Abstract][Full Text] [Related]
17. Possible Role of CYP450 Generated Omega-3/Omega-6 PUFA Metabolites in the Modulation of Blood Pressure and Vascular Function in Obese Children.
Bonafini S; Giontella A; Tagetti A; Marcon D; Montagnana M; Benati M; Gaudino R; Cavarzere P; Karber M; Rothe M; Minuz P; Antonazzi F; Maffeis C; Schunck WH; Fava C
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30400671
[TBL] [Abstract][Full Text] [Related]
18. Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.
Imig JD
Prostaglandins Other Lipid Mediat; 2013; 104-105():2-7. PubMed ID: 23333581
[TBL] [Abstract][Full Text] [Related]
19. Soluble epoxide hydrolase: A potential target for metabolic diseases.
He J; Wang C; Zhu Y; Ai D
J Diabetes; 2016 May; 8(3):305-13. PubMed ID: 26621325
[TBL] [Abstract][Full Text] [Related]
20. EET signaling in cancer.
Panigrahy D; Greene ER; Pozzi A; Wang DW; Zeldin DC
Cancer Metastasis Rev; 2011 Dec; 30(3-4):525-40. PubMed ID: 22009066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
